Capital International Investors 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 6:05 pm Sale |
2024-02-07 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Capital International Investors | 2,819,664 4.000% |
-228,518 (-7.50%) |
Filing |
| 2023-02-13 3:54 pm Purchase |
2023-02-14 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Capital International Investors | 3,048,182 5.300% |
3,048,182 (New Position) |
Filing |